General Information of the Compound
| Compound ID |
CP0062601
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-Methyl-2-pyridin-2-yl-1H-benzoimidazole
Show/Hide
|
||||||||||||||||||
| Synonyms |
5-Methyl-2-pyridin-2-yl-1H-benzoimidazole
5-methyl-2-(pyridin-2-yl)-1H-benzo[d]imidazole
6-Methyl-2-(2-pyridyl)-1H-benzimidazole
6-methyl-2-pyridin-2-yl-1H-benzimidazole
6-methyl-2-pyridin-2-yl-1h-benzo[d]imidazole
7471-12-7
AC1L83HW
AKOS000636609
AKOS002999038
BAS 06347449
BDBM50180733
CCG-24525
CHEMBL352049
DTXSID20323304
HMS1557J02
KB-249126
NSC-403547
NSC403547
SCHEMBL12119033
SCHEMBL124267
TimTec1_008296
US8748618, LD-2-11
ZINC12481420
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C13H11N3
|
||||||||||||||||||
| Molecular Weight |
209.252
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc2nc([nH]c2c1)-c1ccccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H11N3/c1-9-5-6-10-12(8-9)16-13(15-10)11-4-2-3-7-14-11/h2-8H,1H3,(H,15,16)
Show/Hide
|
||||||||||||||||||
| InChIKey |
HFYFOFMVURXVSD-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
7471-12-7
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound